pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›pneumococcal vaccine
drug
save

pneumococcal vaccine

Preclinicalupdated 3mo ago
by Aeolian Biotech LLC
Preclinical
community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying pneumococcal vaccine

  • phase2A Study to Learn About the Safety and Immune Response of a New Pneumococcal Vaccine in Adultscompletedn=1,363
  • N/AStructured Review: To Optimise Management and Prevent Harm in COPDrecruitingn=96
  • phase4Induction of Cross-protective Antibodies for Serogroup 33 by Pneumococcal Conjugate Vaccinesnot yet recruitingn=70
  • phase2Study of a Pneumococcal Conjugate Vaccine in Adults Aged 50 to 84 Years.completedn=750
  • phase3Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine When Co-administered With Routine Pediatric Vaccines in Healthy Infants and Toddlers in Europecompletedn=1,660
  • phase2A Study on the Safety, Reactogenicity, and Immune Response to the GVGH iNTS-GMMA Vaccine Against Invasive Nontyphoidal Salmonella in Adults, Children, and Infantsrecruitingn=516
  • phase2A Dose-Confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19completedn=668

News(1)

  • 10 clinical trials to watch in the second half of 2026
    The biotechnology sector’s upswing accelerated in the first half. Positive results from anticipated trials in lung cancer, Alzheimer’s and multiple autoimmune conditions could add to the momentum.
    biopharma_dive · 1mo ago
indication
Streptococcal Pneumonia
phase
preclinical
Data sources
ClinicalTrials.gov
last refreshed just now
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?